Active substance:
- Clostridium chauvoei, toxoid
- Clostridium chauvoei, strain 1048, cells and equivalent toxoid
- Clostridium chauvoei, strain 658, cells and equivalent toxoid
- Clostridium chauvoei, strain 657, cells and equivalent toxoid
- Clostridium chauvoei, strain 656, cells and equivalent toxoid
- Clostridium chauvoei, strain 655, cells and equivalent toxoid
- Tetanus toxoid adsorbed
- Clostridium septicum, toxoid
- Clostridium perfringens, type C, strain 578, beta toxoid
- Clostridium perfringens, type C, strain 554, beta toxoid
- Clostridium novyi, toxoid
- Bibersteinia trehalosi, serotype T15, strain S1105/84, Inactivated
- Bibersteinia trehalosi, serotype T10, strain S1075/81, Inactivated
- Bibersteinia trehalosi, serotype T4, strain S1085/81, Inactivated
- Bibersteinia trehalosi, serotype T3, strain S1109/84, Inactivated
- Mannheimia haemolytica, serotype A9, strain S994/77, Inactivated
- Mannheimia haemolytica, serotype A7, strain S1078/81, Inactivated
- Mannheimia haemolytica, serotype A6, strain S1084/81, Inactivated
- Mannheimia haemolytica, serotype A2, strain S1126/92, Inactivated
- Mannheimia haemolytica, serotype A1, strain S1006/77, Inactivated
- Immunoglobulins against Clostridium perfringens epsilon toxoid, Equine
Route of administration:
-
Subcutaneous use
Pharmaceutical form:
-
Suspension for injection
Target species:
-
Sheep